Aeolus Pharmaceuticals, Inc. (AOLS.OB) Reports First Quarter Fiscal Year 2008 Financial Results
Today, Aeolus Pharmaceuticals announced that it has generated a net loss of $459,000, or $0.01 per basic share, for the three months ended December 31, 2008. This compares to a loss of $641,000, or $0.02 per basic share, for the three months ended December 31, 2007, a decrease of 28%. John L. McManus, President and CEO, stated, “Results for the quarter continue to demonstrate our success in reducing overhead and successfully partnering with universities and the government to further the development of AEOL 10150. While making wise use of our cash is important, it is also critical that we move…